SEC
SlamSEC
SearchBrowseEarnings

ALIMERA SCIENCES INC

Pharmaceutical Preparations·ALPHARETTA, GA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Alimera Sciences, Inc. was a biopharmaceutical sales company based in Alpharetta, Georgia that specialized in the commercialization and sales of prescription ophthalmic pharmaceuticals.

CEO
Eiswirth Richard S Jr
CFO
Maltz Elliot
Revenue
$54.1M
-8.3% YoY
FY 2023
Adj. EBITDA
-$8.9M
-16.5% margin
FY 2023
Net Income
-$18.1M
-33.5% margin
FY 2023
EPS (Diluted)
-$2.59
FY 2023
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$5.3M
FY 2023
Total Debt
$64.0M
FY 2019
Net Debt
$58.7M
FY 2019
Enterprise Value
—
Debt / EBITDA
-6.6x
FY 2023
EV / EBITDA
—
Employees
—